We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Revealing Early Stages of Alzheimer's Disease with MRI

By MedImaging International staff writers
Posted on 18 May 2010
A major Australian study has provided new clues into the loss of structure in areas of the brain and its potential association with Alzheimer's disease (AD). These findings suggest an accumulation of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory.

AD is characterized by two factors: a build-up of amyloid-beta plaques in the brain, and a loss of neurons. The Commonwealth Scientific and Industrial Research Organization's (CSIRO; Victoria, Australia) Preventative Health flagship theme ;leader, Dr. Cassandra Szoeke, reported the mystery for researchers was that the parts of the brain that had shrunk (atrophied) due to neuron loss were not the same as those showing increased deposits of amyloid-beta.

Using magnetic resonance imaging (MRI) scans to assess Alzheimer's disease-affected brain tissue, the researchers discovered that shrinking (atrophy) of the hippocampus was associated with plaque deposits in the temporal inferior cortex. The study's findings indicate that the increased accumulation of amyloid in the temporal inferior cortex disrupts connections with the hippocampus, causing the neurons to die. "By helping to better understand the mechanisms involved in the progression of the disease, the study may guide the development of new strategies for early diagnosis,” Dr Szoeke said.

The study involved advanced techniques for analyzing and comparing different types of brain scans. Lead researcher was Dr. Perrick Bourgeat, from the Australian e-Health Research Center (Queensland, Australia)--a joint venture between CSIRO and the Queensland Government.

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) Study is being undertaken by CSIRO, the University of Melbourne, Edith Cowan University (Perth), Neurosciences Australia (Victoria), and the Mental Health Institute of Victoria.

The study's findings were reported in April 2010 issue of the journal Neurology.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Australian e-Health Research Center

Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Biopsy Software
Affirm® Contrast
Pocket Fetal Doppler
CONTEC10C/CL
Half Apron
Demi

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.